We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: The HiSeq X Ten, composed of 10 HiSeq X Systems, breaks the USD 1000 barrier for a 30x human genome, enabling population-scale projects on genotypic variation to understand and improve human health (Photo courtesy of Illumina).

New System Breaks Technology and Cost Barriers for High-Throughput Large-Genome Sequencing

A new DNA sequencing system utilizes advanced design features to generate massive throughput and enable the world's first USD 1000 human genome sequence.  More...
28 Jan 2014

Cancer Origin Test Covered by Large Private Health Insurer

A test that identifies the tumor origin in cancer of unknown or uncertain primary will be covered by an in-network service.  More...
28 Jan 2014
Image: Histopathology of papillary craniopharyngioma (Photo courtesy of Jensflorian).

Genetic Mutation Appears to Drive Rare Brain Cancer

A gene mutation associated with several types of cancer may also be responsible for a rare but debilitating brain tumor called papillary craniopharyngioma.  More...
27 Jan 2014
Image: BioCoat Matrigel Invasion Chambers (Photo courtesy of BD Bioscience).

Biomarker Improves Diagnosis of Esophageal Cancer

A biomarker has been discovered that has the potential to improve the diagnosis, prognosis, and treatment of Esophageal Squamous Cell Carcinoma, the major histological form of esophageal cancer, a leading cause of cancer death worldwide.    More...
23 Jan 2014
Image: The Gallios Flow cytometer (Photo courtesy of Beckman Coulter).

Biopsy Test Predicts Aggressive form of Skin Cancer

The genetic profile of immune cells next to a melanoma could lead to more accurate diagnosis to indicate whether a skin cancer is aggressive enough to metastasize.   More...
23 Jan 2014

MicroRNAs Predict Likelihood of Breast Cancer Metastasis

The discovery that breast cancer patients who experienced quick relapses tended to have low levels of the microRNA miR-21 and high levels of the microRNA miR-205 in their tumor tissues suggests that measurement of these two biomarkers could identify women at risk of metastasis.  More...
22 Jan 2014
Image: The Nanodrop 1000 Spectrophotometer (Photo courtesy of Thermo Fisher Scientific).

Blood Test Locates Gene Defects Linked to Cancer

A simple blood test could be developed to determine whether gene mutations associated with pancreatic cancer exist without the need of locating and testing tumor tissue.  More...
21 Jan 2014
New
Gold Member
Collection and Transport System
PurSafe PlusĀ®
Portable Electronic Pipette
Mini 96
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Urine Chemistry Control
Dropper Urine Chemistry Control


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.